Triamcinolone Acetonide
- Product NDC
- 62332-091
- Requested package NDC
- 62332-091-10
- 11-digit product format
- 623320091
- Labeler code
- 62332
- Product ID
- 62332-091_6669782e-f36e-4625-879a-155b8fb814ca
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamcinolone Acetonide
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRA-ARTICULAR; INTRAMUSCULAR
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA218601
- Marketing category
- ANDA
- Marketing start
- 2025-10-17
- Substance
- TRIAMCINOLONE ACETONIDE
- Active strength
- 400 mg/10mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218601-001 | TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218601-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218601-001 | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218601-001 | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218601-001 | TRIAMCINOLONE ACETONIDE | 40MG/ML | INJECTABLE / INJECTION | AB | 2025-10-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218601-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218601-001 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218601-001 | AB | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Triamcinolone Acetonide
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TRIAMCINOLONE ACETONIDE | 400 mg/10mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F446C597KA | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 05c2a9cf-a018-48c0-9c73-2d59d52211d2 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62332-091-10 | Triamcinolone Acetonide | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SUSPENSION | 10 | 5 | |
| 62332-091-10 | Triamcinolone Acetonide | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sagent Pharmaceuticals | 7dbee70b-bd11-4430-b626-97fbb8f01b49 | 2026-02-24 | Warnings, Adverse reactions | 218601 ANDA218601 |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Alembic Pharmaceuticals Inc. | 05c2a9cf-a018-48c0-9c73-2d59d52211d2 | 2025-11-03 | Warnings, Adverse reactions | 218601 ANDA218601 62332-091-10 62332-091 62332009110 |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Alembic Pharmaceuticals Limited | c0b487dd-a47b-42fd-a855-5d237c5651a9 | 2025-11-03 | Warnings, Adverse reactions | 218601 ANDA218601 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1792144 | triamcinolone acetonide 40 MG in 1 ML Injection | PSN | 05c2a9cf-a018-48c0-9c73-2d59d52211d2 | 5 |
| 1085754 | triamcinolone acetonide 40 MG/ML Injectable Suspension | PSN | 05c2a9cf-a018-48c0-9c73-2d59d52211d2 | 5 |
| 1792144 | 1 ML triamcinolone acetonide 40 MG/ML Injection | SCD | 05c2a9cf-a018-48c0-9c73-2d59d52211d2 | 5 |
| 1085754 | triamcinolone acetonide 40 MG/ML Injectable Suspension | SCD | 05c2a9cf-a018-48c0-9c73-2d59d52211d2 | 5 |
| 1792144 | triamcinolone acetonide 40 MG per 1 ML Injection | SY | 05c2a9cf-a018-48c0-9c73-2d59d52211d2 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 62332-091-10 | 62332009110 | 1 VIAL, MULTI-DOSE in 1 CARTON (62332-091-10) / 10 mL in 1 VIAL, MULTI-DOSE | 2025-10-17 | No | No | Current |